Unveiling 3 Analyst Insights On Arcturus Therapeutics

2024-10-02 00:00:35

Benzinga

Latest Ratings for ARCT Date Firm Action From To Mar 2022 Wells Fargo Maintains Overweight Jan 2022 Raymond James Upgrades Underperform Market Perform Nov 2021 Barclays Maintains Underweight View More Analyst Ratings for ARCT View ...

Read Full Article

Latest Benzinga

House Democrats Urge DEA To Speed Up Cannabis Rescheduling
Harris Vs. Trump: Vice President Leads Former President By 5 Points, Walz Favorability Rating Tops Vance Ahead Of VP Debate
Billionaire Investor Who Predicted 2000, 2008 Crashes Says Market Euphoria Will Top Soon, Warns Of 'Black Swan Event'
Slipping Weed Sales In Florida's Market: Is This $100M Bet Really Worth The Hype?
Marijuana Pepsi Has Always Been Proud Of Her Name, More So Now With This Honorific: 'Doctor'
SEC-Approved Cannabis Lender Acquired By Investment Giant, Changes Ticker To $LIEN
What's Going On With Futu Holdings' Stock?
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $12,000 Today
What's Going On With Diamondback Energy Stock?